Make a ppt of 25 slide of detailed review of the latest lancet article on the name change of pcod into pmos
Reading File
Searching the Web
Lancet article PCOD renamed PMOS polycystic ovary syndrome 2025 2026
Searching PubMed
PCOS PMOS renaming nomenclature polycystic ovary
Reading Article
Reading File
Reading Web Page
PCOS PMOS renaming polyendocrine metabolic ovarian syndrome Lancet details criteria diagnosis
Running Command
Writing File
Running Command
Running Command
Your presentation is ready (728 KB, 27 slides — 25 core + 2 bonus):
PMOS Lancet2026 Review
Presentation · PPTX
What's inside (slide-by-slide):
| # | Slide |
|---|---|
| 1 | Title — PCOS → PMOS, gold-on-navy impact slide |
| 2 | Outline — Full 25-topic agenda |
| 3 | Background & Epidemiology — 4 stat boxes (1 in 8, 70% undiagnosed, 10–13% prevalence, #1 endocrine disorder) |
| 4 | Why PCOS was problematic — 6 failure panels (inaccuracy, stigma, missed diagnosis, fragmented care) |
| 5 | 14-Year Timeline — Visual horizontal timeline: 2012 → 2026 |
| 6 | Methodology — Governance + 6 methods (Delphi, NMT, surveys, marketing analysis) |
| 7 | Survey Data — 14,360 voices, stats breakdown |
| 8 | 6 Key Principles — Scientific accuracy, clarity, stigma avoidance, cultural fit, feasibility, evolution |
| 9 | P·M·O·S decoded — Dark full-slide column layout explaining each letter |
| 10 | Polyendocrine hub diagram — 5-node pathophysiology map |
| 11 | Metabolic features — Insulin resistance stats + 6 clinical points |
| 12 | Ovarian dysfunction — Why 'Ovarian' was kept vs. what ovaries do |
| 13 | Full clinical spectrum — 6-domain grid (reproductive, endocrine, metabolic, CVD, psychological, other) |
| 14 | Diagnostic criteria — Old vs new workup comparison table |
| 15 | Reproductive impacts — Infertility, menstrual issues, pregnancy complications, endometrial risk |
| 16 | Cardiometabolic risk — 6-panel risk matrix with relative risks |
| 17 | Psychological burden — 6 domains + expert quotes |
| 18 | Implementation strategy — 4-phase rollout plan |
| 19 | Transition & ICD-11 — Disease classification alignment |
| 20 | Clinical workup table — 7-row before/after comparison (colour-coded) |
| 21 | Therapeutic reframing — Lifestyle, insulin-sensitising, hormonal, fertility treatments |
| 22 | Patient perspectives — Stigma data, patient quotes |
| 23 | Global equity — Cultural testing, LMIC considerations, racial differences, male equivalent debate |
| 24 | Controversies — 6 open questions (male phenotype, retaining 'ovarian', transition speed) |
| 25 | Research implications — GLP-1, genetics, biomarkers, new funding streams |
| 26 | Key Takeaways (bonus) — 8 must-know points |
| 27 | References (bonus) — 8 citations including the primary Lancet paper |
Design: Navy/teal/gold palette, footer with full DOI on every slide, data-driven layouts.
This is a shared conversation. Sign in to Orris to start your own chat.